| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971516 | The Journal of Heart and Lung Transplantation | 2011 | 8 Pages |
Abstract
Use of blood cardioplegia is safe and results in comparable survival and prevalence of adverse events late after HTx. The trend towards greater freedom from chronic rejection and more limited extent of coronary artery disease in grafts protected with blood cardioplegia awaits confirmation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Giovanni Battista MD, Alberto MD, Gianluca MD, Bartolomeo MD, Paolo MD, Alessandro MD, Giuseppe MD,